Risks and benefits of bisphosphonates von Coleman, R E

Volltext

Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial von Coombes, RC, Prof, Kilburn, LS, MSc, Snowdon, CF, MSc, Paridaens, R, Prof, Coleman, RE, Prof, Jones, SE, MD, Jassem, J, Prof, Van de Velde, CJH, Prof, Delozier, T, MD, Alvarez, I, MD, Del Mastro, L, MD, Ortmann, O, Prof, Diedrich, K, Prof, Coates, AS, Prof, Bajetta, E, Prof, Holmberg, SB, MD, Dodwell, D, MD, Mickiewicz, E, MD, Andersen, J, DMSc, Lønning, PE, Prof, Cocconi, G, Prof, Forbes, J, Prof, Castiglione, M, Prof, Stuart, N, MD, Stewart, A, MD, Fallowfield, LJ, Prof, Bertelli, G, MD, Hall, E, PhD, Bogle, RG, MD, Carpentieri, M, PhD, Colajori, E, MD, Subar, M, MD, Ireland, E, MSc, Bliss, JM, Prof

Volltext

Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment von Hadji, P., Aapro, M.S., Body, J.J., Bundred, N.J., Brufsky, A., Coleman, R.E., Gnant, M., Guise, T., Lipton, A.

Volltext

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel von Aapro, M., Abrahamsson, P.A., Body, J.J., Coleman, R.E., Colomer, R., Costa, L., Crinò, L., Dirix, L., Gnant, M., Gralow, J., Hadji, P., Hortobagyi, G.N., Jonat, W., Lipton, A., Monnier, A., Paterson, A.H.G., Rizzoli, R., Saad, F., Thürlimann, B.

Volltext

An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223 von Sartor, O., Coleman, R.E., Nilsson, S., Heinrich, D., Helle, S.I., O’Sullivan, J.M., Vogelzang, N.J., Bruland, Ø., Kobina, S., Wilhelm, S., Xu, L., Shan, M., Kattan, M.W., Parker, C.

Volltext

Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study von Nilsson, S., Cislo, P., Sartor, O., Vogelzang, N.J., Coleman, R.E., O'Sullivan, J.M., Reuning-Scherer, J., Shan, M., Zhan, L., Parker, C.

Volltext

Practical guidance for the management of aromatase inhibitor-associated bone loss von Hadji, P., Body, J.-J., Aapro, M.S., Brufsky, A., Coleman, R.E., Guise, T., Lipton, A., Tubiana-Hulin, M.

Volltext

Bisphosphonates in breast cancer von COLEMAN, R. E

Volltext

Metastatic bone disease: clinical features, pathophysiology and treatment strategies von Coleman, R.E.

Volltext

The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer von Anderson, R.A., Mansi, J., Coleman, R.E., Adamson, D.J.A., Leonard, R.C.F.

Volltext

Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel von Hadji, P., Coleman, R.E., Wilson, C., Powles, T.J., Clézardin, P., Aapro, M., Costa, L., Body, J.-J., Markopoulos, C., Santini, D., Diel, I., Di Leo, A., Cameron, D., Dodwell, D., Smith, I., Gnant, M., Gray, R., Harbeck, N., Thurlimann, B., Untch, M., Cortes, J., Martin, M., Albert, U.-S., Conte, P.-F., Ejlertsen, B., Bergh, J., Kaufmann, M., Holen, I.

Volltext

The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer von Coleman, R E, Winter, M C, Cameron, D, Bell, R, Dodwell, D, Keane, M M, Gil, M, Ritchie, D, Passos-Coelho, J L, Wheatley, D, Burkinshaw, R, Marshall, S J, Thorpe, H

Volltext

Adjuvant bisphosphonates in breast cancer: Are we witnessing the emergence of a new therapeutic strategy? von Coleman, R.E

Volltext

Raman spectroscopic analysis differentiates between breast cancer cell lines von Talari, A. C. S., Evans, C. A., Holen, I., Coleman, R. E., Rehman, Ihtesham Ur

Volltext

Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease von Terpos, E, Berenson, J, Cook, R J, Lipton, A, Coleman, R E

Volltext

Exploring the anti-tumour activity of bisphosphonates in early breast cancer von Winter, M.C, Holen, I, Coleman, R.E

Volltext

Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial von Eastell, R., Adams, J., Clack, G., Howell, A., Cuzick, J., Mackey, J., Beckmann, M.W., Coleman, R.E.

Volltext

Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease von Walkington, L, Webster, J, Hancock, B W, Everard, J, Coleman, R E

Volltext

Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction von Neville-Webbe, H L, Coleman, R E, Holen, I

Volltext

Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04) von Coleman, R.E., Collinson, M., Gregory, W., Marshall, H., Bell, R., Dodwell, D., Keane, M., Gil, M., Barrett-Lee, P., Ritchie, D., Bowman, A., Liversedge, V., De Boer, R.H., Passos-Coelho, J.L., O'Reilly, S., Bertelli, G., Joffe, J., Brown, J.E., Wilson, C., Tercero, J.C., Jean-Mairet, J., Gomis, R., Cameron, D.

Volltext